City Therapeutics (NASDAQ:CTY) Stock Moved Up to Hold by Wall Street Zen

Wall Street Zen upgraded shares of City Therapeutics (NASDAQ:CTY) to a hold rating in a research report released on Saturday morning,Wall Street Zen reports.

City Therapeutics Price Performance

Shares of CTY stock opened at $20.77 on Friday. City Therapeutics has a 12 month low of $19.75 and a 12 month high of $23.88.

Insider Activity at City Therapeutics

In related news, major shareholder Arch Venture Partners Xii, Llc acquired 170,000 shares of the firm’s stock in a transaction on Monday, October 19th. The stock was bought at an average cost of $18.00 per share, with a total value of $3,060,000.00. Following the transaction, the insider owned 13,692,507 shares of the company’s stock, valued at $246,465,126. The trade was a 1.26% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, Director Robert Nelsen acquired 170,000 shares of the stock in a transaction that occurred on Monday, October 19th. The stock was purchased at an average price of $18.00 per share, for a total transaction of $3,060,000.00. Following the completion of the transaction, the director owned 13,692,507 shares in the company, valued at $246,465,126. The trade was a 1.26% increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure.

City Therapeutics Company Profile